Evidence map›Paper›PMID 26314865›Full record

ArticleeLife2015

Chemical perturbation of an intrinsically disordered region of TFIID distinguishes two modes of transcription initiation.

Zhengjian Zhang, Zarko Boskovic, Mahmud M Hussain, Wenxin Hu, Carla Inouye, Han-Je Kim, A Katherine Abole, Mary K Doud, Timothy A Lewis, Angela N Koehler and 2 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. SIRT1 Exon 2-Encoded IDR Gates CREB-Dependent Transcriptional Timing During Fasting.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Emerging Implications of Phase Separation in Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Zhengjian ZhangTranscription Imaging Consortium, Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States.ORCID http://orcid.org/0000-0002-2840-0837
Zarko BoskovicDepartment of Chemistry and Chemical Biology, Howard Hughes Medical Institute, Harvard University, Cambridge, United States.
Mahmud M HussainDepartment of Chemistry and Chemical Biology, Howard Hughes Medical Institute, Harvard University, Cambridge, United States.
Wenxin HuTranscription Imaging Consortium, Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States.
Carla InouyeLi Ka Shing Center for Biomedical and Health Sciences, Department of Molecular and Cell Biology, Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, United States.
Han-Je KimCenter for the Science of Therapeutics, Broad Institute, Cambridge, United States.ORCID http://orcid.org/0000-0002-0305-259X
A Katherine AboleDepartment of Chemistry, University of California, Berkeley, Berkeley, United States.
Mary K DoudCenter for the Science of Therapeutics, Broad Institute, Cambridge, United States.
Timothy A LewisCenter for the Science of Therapeutics, Broad Institute, Cambridge, United States.
Angela N KoehlerCenter for the Science of Therapeutics, Broad Institute, Cambridge, United States.
Stuart L SchreiberDepartment of Chemistry and Chemical Biology, Howard Hughes Medical Institute, Harvard University, Cambridge, United States.ORCID http://orcid.org/0000-0003-1922-7558
Robert TjianTranscription Imaging Consortium, Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States.
Broad Institute · USHoward Hughes Medical Institute · USUniversity of California, Berkeley · US

Funding

Targeting Causal Cancer Genes with Small MoleculesRC2CA148399 · NCI · BROAD INSTITUTE, INC. · PI SCHREIBER, STUART L · 2009 to 2012
$5.2M
Developing Direct Small-Molecule Probes of Myc-Dependent TranscriptionR01CA160860 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI KOEHLER, ANGELA NICOLE · 2012 to 2015
$1.4M
Howard Hughes Medical InstituteNCI NIH HHS N01 CO012400NCI NIH HHS N01-CO-12400NCI NIH HHS R01 CA160860NCI NIH HHS RC2 CA148399
6 · The paper itself

Abstract

Intrinsically disordered proteins/regions (IDPs/IDRs) are proteins or peptide segments that fail to form stable 3-dimensional structures in the absence of partner proteins. They are abundant in eukaryotic proteomes and are often associated with human diseases, but their biological functions have been elusive to study. In this study, we report the identification of a tin(IV) oxochloride-derived cluster that binds an evolutionarily conserved IDR within the metazoan TFIID transcription complex. Binding arrests an isomerization of promoter-bound TFIID that is required for the engagement of Pol II during the first (de novo) round of transcription initiation. However, the specific chemical probe does not affect reinitiation, which requires the re-entry of Pol II, thus, mechanistically distinguishing these two modes of transcription initiation. This work also suggests a new avenue for targeting the elusive IDRs by harnessing certain features of metal-based complexes for mechanistic studies, and for the development of novel pharmaceutical interventions.

Indexed as

Transcription Initiation, GeneticAnimalsDrosophila melanogasterIsomerismProtein ConformationRNA Polymerase IITin CompoundsTranscription Factor TFIIDRNA Polymerase IITin CompoundsTranscription Factor TFIIDbiochemistrychromosomesconformational isomerizationD. melanogastergeneshumanintrinsically disordered proteins/regionsmetal oxo complexespreinitiation complextranscription factorstranscription reinitiation

Identifiers

PMID26314865
PMCPMC4582147
OpenAlexW2121017348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.